ID   DX3-LT5.1 HmR1
AC   CVCL_VS22
SY   LT5.1 HmR1; LT5.1 HmR 1
DR   Wikidata; Q93533703
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LI22 ! DX3-LT5.1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
RA   Sviderskaya E.V., Kallenberg D.M., Bennett D.C.;
RT   "The Wellcome Trust functional genomics cell bank: holdings.";
RL   Pigment Cell Melanoma Res. 23:147-150(2010).
//